BMS-986036
BMS-986036 Uses, Dosage, Side Effects, Food Interaction and all others data.
BMS-986036 is under investigation in clinical trial NCT03486899 (A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis).
| Trade Name | BMS-986036 |
| Generic | Pegbelfermin |
| Pegbelfermin Other Names | BMS-986036, Pegbelfermin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BMS-986036
